Article Text

PDF
Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy
  1. F G Hampson1,
  2. S W Hancock2,
  3. R A Primhak3
  1. 1Department of Microbiology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK
  2. 2Intensive Care Unit, Sheffield Children’s Hospital, Western Bank, Sheffield S10 2TH, UK
  3. 3Directorate of Respiratory Medicine, Sheffield Children’s Hospital, Western Bank, Sheffield S10 2TH, UK
  1. Correspondence to:
    Dr F G Hampson
    Department of Microbiology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK; Fay.Hampson{at}sth.nhs.uk

Statistics from Altmetric.com

Although unusual in the UK to date, sepsis due to community acquired meticillin resistant Staphylococcus aureus (CA-MRSA) is an increasing concern globally. CA-MRSA strains typically produce the exotoxin Panton-Valentine leukocidin (PVL), a virulence factor associated with severe, rapidly progressive, systemic disease including soft tissue infections and necrotising pneumonia, which has a mortality rate as high as 75%.1,2

A 14 year old boy presented with septicaemia and disseminated foci of infection including necrotising pneumonia, septic arthritis of the left knee, and deep vein thrombosis of the left …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.